Angiostatin, an endogenous angiogenesis inhibitor generated by the proteolytic cleavage of plasminogen, was recently reported to contribute to the development of Alzheimer’s disease (AD). The gene discussed is PLG; the disease is early-onset autosomal dominant Alzheimer disease.